US Broker Ratings

Centene Corporation (CNC) Stock Analysis: Navigating Growth and Challenges in the Healthcare Sector

Centene Corporation (NYSE: CNC), a healthcare giant in the United States, is a notable player in the healthcare plans industry. With a market capitalization of $18.46..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Exploring a 75.86% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure to innovative healthcare solutions targeting rare..

Solventum Corporation (SOLV) Stock Analysis: Exploring an 18.85% Upside in the Healthcare Sector

Solventum Corporation (NYSE: SOLV) has emerged as a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 73.63% Potential Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, offers an intriguing investment opportunity with a remarkable potential upside of 73.63%, according to..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and Impressive Growth Potential

Tenet Healthcare Corporation (NYSE: THC) stands out in the healthcare sector, boasting a market cap of $18.04 billion. This diversified healthcare services company, headquartered in Dallas,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A Healthcare Giant with 21% Potential Upside

For investors eyeing opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents a compelling case. With a market capitalization of $33.28 billion, this..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating the 7.08% Potential Upside for Investors

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Royalty Pharma (RPRX) Stock Analysis: A Biotech Gem with an 18% Upside Potential

Royalty Pharma plc (RPRX) stands as a unique player in the biotechnology sector, strategically positioned at the crossroads of healthcare innovation and financial acumen. As the..

Regeneron Pharmaceuticals (REGN): Investor Outlook on a Biotech Leader with 14.55% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology sector, continues to capture investor interest with its robust pipeline and promising growth prospects. Based..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 12.64% Potential Upside Amidst Healthcare Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors driven by..

Johnson & Johnson (JNJ) Stock Analysis: Exploring the 6.96% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to draw investor attention with its robust market presence and promising growth indicators. The..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 10% Potential Upside in the Healthcare Giant

AbbVie Inc. (NYSE: ABBV), a leading player in the healthcare sector, stands out with a market capitalization of $387.34 billion. As a prominent biopharmaceutical company, AbbVie..

Zoetis Inc. (ZTS) Stock Analysis: Unpacking a 45% Potential Upside for Investors

Investors with an eye on the healthcare sector might find Zoetis Inc. (NYSE: ZTS) a compelling opportunity, especially given its potential upside of 45.51% as highlighted..

Novartis AG (NVS) Stock Analysis: A Healthcare Giant with Robust Revenue Growth and Dividend Potential

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, stands as a formidable entity in the global pharmaceutical landscape. With a market capitalization of..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Healthcare Giant with a 15.46% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a leading player in the global healthcare sector, presents an intriguing opportunity for investors seeking exposure in the drug manufacturing industry...

Molina Healthcare Inc (MOH) Investor Outlook: Navigating Upside Potential Amidst Healthcare Sector Dynamics

Molina Healthcare Inc (NYSE: MOH), a formidable player in the healthcare plans industry, presents a fascinating prospect for investors seeking opportunities within the healthcare sector. With..

DexCom, Inc. (DXCM) Investor Outlook: Analyzing a 56% Potential Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a leader in the medical devices industry, is capturing the attention of investors with a notable 56.29% potential upside, as indicated by..

Novo Nordisk A/S (NVO) Investor Outlook: Assessing a 30.71% Upside Potential

Novo Nordisk A/S (NYSE: NVO) stands as a towering entity in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $210.03..

STERIS plc (STE) Stock Analysis: Exploring 5.82% Upside Potential and Robust Revenue Growth

For investors eyeing opportunities in the healthcare sector, STERIS plc (NYSE: STE) presents an intriguing prospect. With a market capitalization of $25.89 billion, this leading player..

Edwards Lifesciences Corporatio (EW)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds